| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
88,757 |
77,066 |
$7.07M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,720 |
9,225 |
$1.87M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,208 |
11,350 |
$1.59M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,835 |
8,564 |
$778K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,747 |
4,178 |
$460K |
| 36415 |
Collection of venous blood by venipuncture |
30,959 |
27,676 |
$177K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,194 |
1,165 |
$107K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
856 |
806 |
$95K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,788 |
2,822 |
$69K |
| 80053 |
Comprehensive metabolic panel |
5,470 |
4,960 |
$65K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
511 |
489 |
$65K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,416 |
3,052 |
$54K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,537 |
1,402 |
$47K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
848 |
788 |
$39K |
| 71045 |
Radiologic examination, chest; single view |
512 |
478 |
$25K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,170 |
1,075 |
$25K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
840 |
805 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,364 |
5,896 |
$19K |
| 81514 |
|
81 |
79 |
$18K |
| 0001A |
|
665 |
636 |
$16K |
| 0002A |
|
613 |
601 |
$16K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
363 |
348 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
796 |
687 |
$15K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,220 |
1,125 |
$14K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,222 |
1,127 |
$14K |
| 85027 |
|
3,654 |
3,225 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,884 |
1,843 |
$14K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
122 |
117 |
$13K |
| 20610 |
|
57 |
42 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,712 |
1,535 |
$12K |
| 94060 |
|
62 |
62 |
$12K |
| 87631 |
|
322 |
306 |
$10K |
| 91320 |
|
133 |
132 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
195 |
188 |
$7K |
| 70450 |
Computed tomography, head or brain; without contrast material |
42 |
38 |
$6K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
33 |
30 |
$6K |
| Q3014 |
Telehealth originating site facility fee |
233 |
227 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
431 |
416 |
$5K |
| 87510 |
|
1,165 |
1,056 |
$4K |
| 85610 |
|
1,785 |
1,531 |
$4K |
| 90480 |
|
150 |
148 |
$4K |
| 83605 |
|
1,136 |
1,027 |
$4K |
| 97810 |
|
132 |
60 |
$4K |
| 80061 |
Lipid panel |
352 |
347 |
$4K |
| 87660 |
|
1,165 |
1,056 |
$4K |
| 92557 |
|
44 |
42 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
303 |
297 |
$3K |
| 90686 |
|
279 |
275 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
28 |
25 |
$3K |
| 87480 |
|
1,165 |
1,056 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
503 |
488 |
$3K |
| 84703 |
|
438 |
394 |
$3K |
| 0004A |
|
121 |
119 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
89 |
82 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
144 |
76 |
$2K |
| 0352U |
|
87 |
85 |
$2K |
| 83735 |
|
1,236 |
1,132 |
$2K |
| 92567 |
|
350 |
343 |
$2K |
| 31575 |
|
12 |
12 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
167 |
163 |
$1K |
| 11721 |
|
92 |
89 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
669 |
620 |
$1K |
| 97811 |
|
136 |
60 |
$1K |
| 0124A |
|
38 |
31 |
$1K |
| 0072A |
|
30 |
30 |
$961.20 |
| 73630 |
|
88 |
77 |
$947.35 |
| 94726 |
|
47 |
47 |
$800.27 |
| 82248 |
|
531 |
506 |
$797.44 |
| 94729 |
|
48 |
48 |
$734.74 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
528 |
458 |
$726.92 |
| 84484 |
|
305 |
246 |
$710.45 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
772 |
646 |
$661.63 |
| 0071A |
|
18 |
18 |
$592.82 |
| 82077 |
|
446 |
408 |
$489.87 |
| 86140 |
|
431 |
407 |
$463.10 |
| 0064A |
|
18 |
17 |
$461.53 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
28 |
25 |
$428.46 |
| 86780 |
|
41 |
39 |
$383.72 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
103 |
99 |
$377.06 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
527 |
407 |
$369.41 |
| 87081 |
|
138 |
131 |
$326.45 |
| 83690 |
|
134 |
126 |
$314.62 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
167 |
158 |
$308.06 |
| 88142 |
|
31 |
27 |
$277.85 |
| 81003 |
|
100 |
95 |
$223.24 |
| 0003A |
|
13 |
13 |
$188.11 |
| 81001 |
|
165 |
159 |
$179.43 |
| 85018 |
|
151 |
136 |
$162.73 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
140 |
133 |
$154.90 |
| 0031A |
|
18 |
14 |
$133.83 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
111 |
106 |
$133.61 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
13 |
13 |
$107.87 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
181 |
168 |
$104.19 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15 |
13 |
$87.10 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
41 |
37 |
$54.38 |
| 85730 |
|
74 |
74 |
$54.36 |
| S0028 |
Injection, famotidine, 20 mg |
14 |
14 |
$48.99 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
94 |
44 |
$37.24 |
| 82962 |
|
12 |
12 |
$14.76 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
61 |
52 |
$10.81 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
27 |
$5.30 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
23 |
18 |
$5.16 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
27 |
24 |
$0.00 |
| A9270 |
Non-covered item or service |
132 |
24 |
$0.00 |
| 85379 |
|
12 |
12 |
$0.00 |
| 80143 |
|
27 |
25 |
$0.00 |
| 84100 |
|
14 |
13 |
$0.00 |
| 80179 |
|
26 |
25 |
$0.00 |
| 84145 |
|
12 |
12 |
$0.00 |